Published in Eur J Endocrinol on August 01, 2003
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci (2006) 1.96
Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. J Pain (2007) 1.80
Ancient exaptation of a CORE-SINE retroposon into a highly conserved mammalian neuronal enhancer of the proopiomelanocortin gene. PLoS Genet (2007) 1.67
Alternative life histories shape brain gene expression profiles in males of the same population. Proc Biol Sci (2005) 1.61
Profiling signaling peptides in single mammalian cells using mass spectrometry. Anal Chem (2006) 1.38
UV radiation and the skin. Int J Mol Sci (2013) 1.37
Identification of neuronal enhancers of the proopiomelanocortin gene by transgenic mouse analysis and phylogenetic footprinting. Mol Cell Biol (2005) 1.30
Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis. Crit Care (2009) 1.20
Ion channels and signaling in the pituitary gland. Endocr Rev (2010) 1.14
A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in pomc null mice. Endocrinology (2006) 1.04
Gestational choline supplementation normalized fetal alcohol-induced alterations in histone modifications, DNA methylation, and proopiomelanocortin (POMC) gene expression in β-endorphin-producing POMC neurons of the hypothalamus. Alcohol Clin Exp Res (2013) 1.00
Convergent evolution of two mammalian neuronal enhancers by sequential exaptation of unrelated retroposons. Proc Natl Acad Sci U S A (2011) 0.96
Gene-expression signatures of Atlantic salmon's plastic life cycle. Gen Comp Endocrinol (2009) 0.94
Science of self-preservation: how melanocortin action in the brain modulates body weight, blood pressure, and ischemic damage. Circulation (2009) 0.91
Classification of Large Cellular Populations and Discovery of Rare Cells Using Single Cell Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. Anal Chem (2015) 0.87
Fetal alcohol spectrum disorders and their transmission through genetic and epigenetic mechanisms. Front Genet (2014) 0.86
Differential hypothalamic-pituitary-adrenal activation of the neuroactive steroids pregnenolone sulfate and deoxycorticosterone in healthy controls and alcohol-dependent subjects. Psychoneuroendocrinology (2007) 0.86
Enhancer turnover and conserved regulatory function in vertebrate evolution. Philos Trans R Soc Lond B Biol Sci (2013) 0.85
Germline ablation of VGF increases lipolysis in white adipose tissue. J Endocrinol (2012) 0.85
Expression of genes related to the hypothalamic-pituitary-adrenal axis in murine fetal lungs in late gestation. Reprod Biol Endocrinol (2010) 0.85
Engineering the melanocortin-4 receptor to control constitutive and ligand-mediated G(S) signaling in vivo. PLoS One (2007) 0.85
Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia. Physiol Behav (2008) 0.85
Fetal alcohol exposure alters proopiomelanocortin gene expression and hypothalamic-pituitary-adrenal axis function via increasing MeCP2 expression in the hypothalamus. PLoS One (2014) 0.83
Radiation-induced change in lymphocyte proliferation and its neuroendocrine regulation: dose-response relationship and pathophysiological implications. Nonlinearity Biol Toxicol Med (2004) 0.82
Glycyl-glutamine (beta-endorphin(30-31)) inhibits morphine-induced dopamine efflux in the nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.78
Positive selection of co-opted mobile genetic elements in a mammalian gene: If you can't beat them, join them. Mob Genet Elements (2012) 0.78
Characterization of two pro-opiomelanocortin gene variants and their effects on carcass traits in beef cattle. BMC Genet (2011) 0.78
Melanocortin systems on pigment dispersion in fish chromatophores. Front Endocrinol (Lausanne) (2012) 0.77
Hsa-miR-34a mediated repression of corticotrophin releasing hormone receptor 1 regulates pro-opiomelanocortin expression in patients with complex regional pain syndrome. J Transl Med (2016) 0.77
BDNF pro-peptide regulates dendritic spines via caspase-3. Cell Death Dis (2016) 0.77
Spontaneous and CRH-Induced Excitability and Calcium Signaling in Mice Corticotrophs Involves Sodium, Calcium, and Cation-Conducting Channels. Endocrinology (2016) 0.76
Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism. Front Endocrinol (Lausanne) (2016) 0.76
Regulation of synaptic functions in central nervous system by endocrine hormones and the maintenance of energy homoeostasis. Biosci Rep (2012) 0.76
Posttranslational modifications of proopiomelanocortin in vertebrates and their biological significance. Front Endocrinol (Lausanne) (2013) 0.76
Addiction and the adrenal cortex. Endocr Connect (2013) 0.76
Lactation undernutrition leads to multigenerational molecular programming of hypothalamic gene networks controlling reproduction. BMC Genomics (2016) 0.75
α-Melanocyte stimulating hormone promotes muscle glucose uptake via melanocortin 5 receptors. Mol Metab (2016) 0.75
First Behavioural Characterisation of a Knockout Mouse Model for the Transforming Growth Factor (TGF)-β Superfamily Cytokine, MIC-1/GDF15. PLoS One (2017) 0.75
"patients can have as many gene variants as they damn well please": why contemporary genetics presents us daily with a version of Hickam's dictum. J Clin Endocrinol Metab (2012) 0.75
Biomimetic proopiomelanocortin suppresses capsaicin-induced sensory irritation in humans. Res Pharm Sci (2016) 0.75
How should we interrogate the hypothalamic-pituitary-adrenal axis in patients with suspected hypopituitarism? BMC Endocr Disord (2016) 0.75
Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations. F1000Res (2017) 0.75
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med (1990) 2.73
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects. J Clin Endocrinol Metab (1995) 1.49
Antitumoral effect of the bisphosphonate zoledronic acid against visceral metastases in an adrenocortical cancer patient. Ann Oncol (2009) 1.38
Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res (2001) 1.30
Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann N Y Acad Sci (2002) 1.21
A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism. J Clin Invest (2000) 1.19
Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism. J Clin Endocrinol Metab (2008) 1.14
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. Endocr Relat Cancer (2013) 1.14
Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J Clin Endocrinol Metab (1997) 1.12
Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREMtau in the human adrenocortical cancer cell line H295R. J Clin Endocrinol Metab (2000) 1.12
Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study. J Clin Endocrinol Metab (2003) 1.11
Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett (1994) 1.06
Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol (Oxf) (1994) 1.05
Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab (2000) 1.01
Risk factors for conversion and complications after unilateral laparoscopic adrenalectomy. Br J Surg (2011) 1.00
Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries. J Clin Invest (1985) 0.98
High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors. J Clin Endocrinol Metab (2000) 0.98
Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J Clin Endocrinol Metab (1994) 0.97
Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations. J Clin Endocrinol Metab (2000) 0.96
Characterization of proopiomelanocortin transcripts in human nonpituitary tissues. Proc Natl Acad Sci U S A (1987) 0.95
Plasma lipotropin increase in man after growth hormone administration. Comparison between extractive and biosynthetic hormones. J Clin Endocrinol Metab (1983) 0.94
Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker). Am J Med (1976) 0.93
The new steroid analog RU 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab (1984) 0.92
[In vitro biosynthesis of bovine beta-lipotropic hormone]. Can J Biochem (1974) 0.89
Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity. Eur J Endocrinol (2008) 0.89
MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines. J Clin Endocrinol Metab (2015) 0.89
Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors. Eur J Endocrinol (2001) 0.88
Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome. J Clin Endocrinol Metab (1986) 0.87
Comparison of computerized tomography and magnetic resonance imaging for the examination of the pituitary gland in patients with Cushing's disease. Clin Endocrinol (Oxf) (1993) 0.86
Role for NF-kappa B in mediating the effects of hyperoxia on IGF-binding protein 2 promoter activity in lung alveolar epithelial cells. Biochim Biophys Acta (1999) 0.86
Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia. Mol Genet Metab (2008) 0.84
Development of liver disease despite mannose treatment in two patients with CDG-Ib. Mol Genet Metab (2007) 0.84
Liver hepatoblastoma and multiple OXPHOS deficiency in the follow-up of a patient with methylmalonic aciduria. Mol Genet Metab (2008) 0.84
High expression of the POU factor Brn3a in aggressive neuroendocrine tumors. J Clin Endocrinol Metab (1997) 0.84
Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. J Clin Endocrinol Metab (1998) 0.83
Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies. J Clin Endocrinol Metab (1988) 0.83
High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta. Clin Endocrinol (Oxf) (1999) 0.83
Detection of the messenger RNAs coding for the opioid peptide precursors in pituitary and adrenal by "in situ' hybridization: study in several mammal species. Neurosci Lett (1985) 0.83
High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab (1996) 0.82
Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms. Endocrinol Metab Clin North Am (2000) 0.82
Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. J Clin Endocrinol Metab (1994) 0.82
Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology. Br J Clin Pharmacol (1994) 0.82
Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours. Clin Endocrinol (Oxf) (1998) 0.82
Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism. J Endocrinol Invest (2007) 0.82
Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients. Neurosci Lett (1985) 0.81
Monoclonality of corticotroph macroadenomas in Cushing's disease. J Clin Endocrinol Metab (1992) 0.81
PTH mRNA transcription analysis in infantile tumors associated with hypercalcemia. Cancer (1988) 0.81
RT-PCR analysis of corticotroph-associated genes expression in carcinoid tumours in the ectopic-ACTH syndrome. Eur J Endocrinol (2006) 0.80
Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor. J Mol Endocrinol (1999) 0.80
The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest (1996) 0.80
Expression of the prohormone convertase PC2 correlates with the presence of corticotropin-like intermediate lobe peptide in human adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab (1994) 0.80
Proopiomelanocortin gene expression in normal and tumoral human lung. J Clin Endocrinol Metab (1991) 0.80
Peptides related to the NH2-terminal end of proopiocortin in man. J Clin Endocrinol Metab (1983) 0.80
Recent advances in the pathogenesis of adrenocortical tumours. Eur J Endocrinol (1995) 0.80
Pro-opiomelanocortin gene expression in human phaeochromocytomas. J Mol Endocrinol (1989) 0.79
Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumours. Clin Endocrinol (Oxf) (1992) 0.79
The secretory granule peptides 7B2 and CCB are sensitive biochemical markers of neuro-endocrine bronchial tumours in man. Clin Endocrinol (Oxf) (1991) 0.79
Characterization of lipotropin-, corticotropin-, and beta-endorphin-immunoreactive materials secreted in vitro by a human pituitary adenoma responsible for a case of Nelson's syndrome. J Clin Endocrinol Metab (1979) 0.79
Corticotrophin-like intermediary lobe peptide as a marker of alternate pro-opiomelanocortin processing in ACTH-producing non-pituitary tumours. Clin Endocrinol (Oxf) (1989) 0.79
High levels of tyrosine phosphorylated proto-ret in sporadic phenochromocytomas. Cancer Res (2000) 0.79
Phosphorylated forms of adrenocorticotropin and corticotropin-like intermediary lobe peptide in human tumors. Eur J Endocrinol (1994) 0.79
Human beta-melanocyte-stimulating hormone revisited. Proc Natl Acad Sci U S A (1986) 0.78
Video-assisted thoracoscopic surgery as a first-line treatment for mediastinal parathyroid adenomas: strategic value of imaging. Eur J Endocrinol (2004) 0.78
Biochemistry of the hypothalamus in Parkinson's disease. Neurology (1984) 0.78
Plasma pro-opiomelanocortin fragments and adrenal steroids following administration of metyrapone to normal and hirsute women. J Endocrinol Invest (1988) 0.78
Cushing's syndrome and pregnancy: aetiologies and prognosis in twenty-two patients. Eur J Med (1992) 0.78
Ectopic ACTH Cushing's syndrome: V3 vasopressin receptor but not CRH receptor gene expression in a pulmonary carcinoid tumor. Horm Res (1998) 0.78
Insights into the molecular biology of adrenocortical tumors. Exp Clin Endocrinol Diabetes (2007) 0.78
Transient inhibition of RU 486 antiglucocorticoid action by dexamethasone. J Clin Endocrinol Metab (1990) 0.78
Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumourigenesis. Eur J Endocrinol (1995) 0.78
Silent necrosis of a pituitary corticotroph adenoma revealed by timely magnetic resonance imaging: a cause of spontaneous remission of Cushing's disease. Eur J Endocrinol (1994) 0.78
[Pigmented micronodular dysplasia of the adrenal glands and Carney complex]. Ann Endocrinol (Paris) (2005) 0.78
ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas. Endocr Res (1999) 0.78
[Metastatic pulmonary carcinoma, revealed by Cushing syndrome, initially considered to have a pituitary origin. Course over 25 years]. Presse Med (1995) 0.77
Regulated expression of mature human insulin in the liver of transgenic mice. FEBS Lett (1998) 0.77
[Secretion of a beta lipotropine type substances by a corticomelanotropic adenoma in Nelson's syndrome (author's transl)]. Nouv Presse Med (1977) 0.77
Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors. Oncogene (1999) 0.77
Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin. Clin Endocrinol (Oxf) (1993) 0.77
Pituitary-like proopiomelanocortin transcripts in human Leydig cell tumors. J Clin Invest (1990) 0.77
[How should the plasma ACTH level in treated Addison's disease patients be interpreted?]. Ann Endocrinol (Paris) (1989) 0.77
Variable modes of proopiomelanocortin gene transcription in human tumors. Mol Endocrinol (1989) 0.77
[Adrenomegaly and other masses of the adrenal area. Diagnostic and therapeutic approaches]. Ann Endocrinol (Paris) (1988) 0.77
[Ectopic secretion of ACTH and of related peptides (LPHs, beta-endorphin, "16K"). Evidence for a common precursor]. Horm Res (1980) 0.77
Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia). J Med Genet (2009) 0.77
Functional analysis of the human pro-opiomelanocortin promoter in the small cell lung carcinoma cell line DMS-79. J Mol Endocrinol (1995) 0.77
Dynamics and characterization of plasma immunoreactive beta-melanocyte stimulating hormone in hemodialysis patients: its relationship to ACTH. J Clin Endocrinol Metab (1977) 0.77
[Aberrant expression of the GIP (Gastric Inhibitory Polypeptide) receptor in an adrenal cortical adenoma responsible for a case of food-dependent Cushing's syndrome]. Bull Acad Natl Med (1998) 0.77
Pituitary beta-endorphin not involved in pain control in some pathophysiological conditions. Lancet (1984) 0.76